ARPA-H and XPRIZE Push Longevity Science Toward Measurable Function
Alicia Jackson of ARPA-H and Jamie Justice of XPRIZE argue that longevity science should be judged less by promises of longer life than by whether it can compress the years people spend in decline. In a discussion moderated by Latif Nasser, they describe two funding models — government milestone funding and outcome-based prizes — meant to force evidence around healthspan interventions before hype or institutional inertia takes over. Both frame the central bet as restoring measurable function in areas such as muscle, cognition and immunity, while testing even radical ideas against predefined standards.
The Aspen Institute·Jun 25, 2026·18 min read